PT94292A - Processo para a preparacao de uma composicao farmaceutica sob a forma de um aerossol contendo derivados de compostos macrociclicos - Google Patents

Processo para a preparacao de uma composicao farmaceutica sob a forma de um aerossol contendo derivados de compostos macrociclicos

Info

Publication number
PT94292A
PT94292A PT94292A PT9429290A PT94292A PT 94292 A PT94292 A PT 94292A PT 94292 A PT94292 A PT 94292A PT 9429290 A PT9429290 A PT 9429290A PT 94292 A PT94292 A PT 94292A
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical composition
aerosol containing
macromolecular compounds
compounds
Prior art date
Application number
PT94292A
Other languages
English (en)
Other versions
PT94292B (pt
Inventor
Alan Anthony Norris
Dale Michael Jackson
Sohei Makino
Takeshi Fukuda
Ikuo Akutsu
Original Assignee
Fujisawa Pharmaceutical Co
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898912935A external-priority patent/GB8912935D0/en
Priority claimed from JP2096045A external-priority patent/JPH03291225A/ja
Application filed by Fujisawa Pharmaceutical Co, Fisons Plc filed Critical Fujisawa Pharmaceutical Co
Publication of PT94292A publication Critical patent/PT94292A/pt
Publication of PT94292B publication Critical patent/PT94292B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Portable Lighting Devices Or Systems Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
PT94292A 1989-06-06 1990-06-06 Processo para a preparacao de uma composicao farmaceutica sob a forma de um aerossol contendo derivados de compostos macrociclicos PT94292B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898912935A GB8912935D0 (en) 1989-06-06 1989-06-06 Method of treatment
JP2096045A JPH03291225A (ja) 1990-04-09 1990-04-09 抗喘息薬

Publications (2)

Publication Number Publication Date
PT94292A true PT94292A (pt) 1991-02-08
PT94292B PT94292B (pt) 1997-01-31

Family

ID=26295442

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94292A PT94292B (pt) 1989-06-06 1990-06-06 Processo para a preparacao de uma composicao farmaceutica sob a forma de um aerossol contendo derivados de compostos macrociclicos

Country Status (13)

Country Link
EP (1) EP0475994B1 (pt)
JP (1) JP2508918B2 (pt)
KR (1) KR0147852B1 (pt)
AT (1) ATE111353T1 (pt)
AU (1) AU639460B2 (pt)
CA (1) CA2054203C (pt)
DE (1) DE69012560T2 (pt)
DK (1) DK0475994T3 (pt)
ES (1) ES2061043T3 (pt)
GR (1) GR1000738B (pt)
IE (1) IE64214B1 (pt)
PT (1) PT94292B (pt)
WO (1) WO1990014826A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208228A (en) * 1989-11-13 1993-05-04 Merck & Co., Inc. Aminomacrolides and derivatives having immunosuppressive activity
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
US5147877A (en) * 1991-04-18 1992-09-15 Merck & Co. Inc. Semi-synthetic immunosuppressive macrolides
US5514686A (en) * 1991-04-26 1996-05-07 Fujisawa Pharmaceutical Co., Ltd. Use of macrolide compounds for eye diseases
US5565560A (en) * 1991-05-13 1996-10-15 Merck & Co., Inc. O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5250678A (en) 1991-05-13 1993-10-05 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5162334A (en) * 1991-05-13 1992-11-10 Merck & Co., Inc. Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
US5189042A (en) * 1991-08-22 1993-02-23 Merck & Co. Inc. Fluoromacrolides having immunosuppressive activity
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
ZA926812B (en) 1991-09-09 1993-04-28 Merck & Co Inc O-heteroaryl,o-alkylheteroaryl,o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosupressive activity
GB9218027D0 (en) * 1992-08-25 1992-10-14 Fisons Plc Novel method of treatment
US5693648A (en) * 1994-09-30 1997-12-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
AU2002952559A0 (en) * 2002-11-08 2002-11-21 Fujisawa Pharmaceutical Co., Ltd. New use
WO2004069223A2 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical compositions comprising immunosuppressants and uses thereof
CA2552305A1 (en) * 2003-12-30 2005-07-14 Astellas Pharma Inc. Use of macrolides for treating or preventing airflow obstruction
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
KR102293890B1 (ko) * 2018-12-11 2021-08-27 주식회사 몰젠바이오 신규 화합물 및 이를 포함하는 발모 촉진용 조성물
US12011497B2 (en) 2018-12-11 2024-06-18 Molgenbio Co. Ltd. Compounds, compositions containing same, and use thereof for promoting hair growth

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
PH26083A (en) * 1987-11-09 1992-02-06 Sandoz Ltd 11, 28-dioxa-4-azatricyclo [22.3.1.04.9) octacos-18-ene derivatives and pharmaceutical compositions containing them and method of use thereof
GB8802229D0 (en) * 1988-02-02 1988-03-02 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives

Also Published As

Publication number Publication date
CA2054203A1 (en) 1990-12-07
EP0475994B1 (en) 1994-09-14
KR0147852B1 (ko) 1998-08-17
DE69012560D1 (de) 1994-10-20
ATE111353T1 (de) 1994-09-15
AU639460B2 (en) 1993-07-29
DE69012560T2 (de) 1995-03-09
JPH05503283A (ja) 1993-06-03
AU5721490A (en) 1991-01-07
IE64214B1 (en) 1995-07-26
WO1990014826A1 (en) 1990-12-13
GR1000738B (el) 1992-12-30
ES2061043T3 (es) 1994-12-01
JP2508918B2 (ja) 1996-06-19
DK0475994T3 (da) 1995-01-09
PT94292B (pt) 1997-01-31
EP0475994A1 (en) 1992-03-25
IE902002L (en) 1990-12-06
GR900100428A (en) 1991-11-15
KR920700638A (ko) 1992-08-10
CA2054203C (en) 2001-08-21

Similar Documents

Publication Publication Date Title
PT94292A (pt) Processo para a preparacao de uma composicao farmaceutica sob a forma de um aerossol contendo derivados de compostos macrociclicos
EP0691333A3 (pt)
HUT56365A (en) Process for producing antimuscarine quinuclidine derivatives having bronchodilator effect and pharmaceutical compositions comprising same as active ingredient
BR0009651A (pt) Composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, e, método para tratar artrite reumatóide e uma doença obstrutiva das vias aéreas
HUT37128A (en) Process for the production of dihydropyridazinone-derivatives, as well as of pharmaceutical preparations containing these derivatives as agent
BRPI9909282A (pt) compostos de éter aminociclohexílicos e usos dos mesmos.
ATE199083T1 (de) Terphenylverbindungen und sie enthaltende arzneimittel
IL90424A (en) Cephem derivatives, processes for the preparation thereof and pharmaceutical composition containing the same
DE3574256D1 (en) New cephem compounds, process for preparation thereof and pharmaceutical compositions containing them
IL86080A0 (en) Bicyclic compounds,processes for preparation thereof and pharmaceutical composition comprising the same
IL94885A0 (en) Muramyl dipeptide derivatives,their preparation and pharmaceutical compositions containing them
AU655869B2 (en) An amphoteric tricyclic compound
AU625238B2 (en) Anti-psychotic piperidylbenzimidazole compounds
RU95104235A (ru) Агент для контроля плодовитости и содержащая его фармацевтическая композиция
BR9813775A (pt) Uso de um composto, processo para o tratamento de uma condição de cefaléia vascular, e, composição farmacêutica adequada para uso no tratamento de uma condição de cefaléia vascular.
DE3070768D1 (en) 1-((substituted-naphthyl)ethyl)-imidazole derivatives, pharmaceutical compositions containing them and methods of making them
SE8603589L (sv) Metylendioxifenantren- och stilbenderivat
BR0109252A (pt) Composto, processo para produzir um composto, composição farmacêutica, e, uso de um composto ou de uma composição
ATE109485T1 (de) Derivate von n-(vincristinyl-23) und n- (noranhydro-5-vinblastinyl-23) von amino-1- methylphosphonsäure, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
EP0322248A3 (en) Compounds effective against cerebral insufficiency
SE8405332L (sv) 2h-azeto (2,1-a)-isokinolinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem
JPH04128220A (ja) 抗ヘルペスウイルス剤

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19961004

PC3A Transfer or assignment

Owner name: ASTELLAS PHARMA INC., JP

Effective date: 20060310

PC3A Transfer or assignment

Owner name: ASTELLAS PHARMA INC., JP

Effective date: 20060413

Owner name: FUJISAWA PHARMACEUTICAL COMPANY LIMITED, JP

Effective date: 20060413

PD3A Change of proprietorship

Owner name: FISONS LIMITED, CH

Effective date: 20060413

TE3A Change of address (patent)

Owner name: FISONS LIMITED, GB

Effective date: 20060413

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20080404